Lucid Diagnostics Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.0M
Doctors Paid
4,775
Transactions
8,989
2024 Total
$393,957
Payment Breakdown by Category
Research$1.3M (64.2%)
Consulting$462,154 (22.5%)
Food & Beverage$241,355 (11.8%)
Travel$22,730 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 180 | 64.2% |
| Consulting Fee | $462,154 | 167 | 22.5% |
| Food and Beverage | $241,355 | 8,594 | 11.8% |
| Travel and Lodging | $22,730 | 21 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,790 | 27 | 0.4% |
Payments by Type
Research
$1.3M
180 transactions
General
$734,028
8,809 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Multicenter Case-Control Study of the Efficacy of EsoGuardO on Samples Collected Using EsoCheckO, versus Esophagogastroduodenoscopy, for the Diagnosis of Barretts Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma | $411,603 | 0 | 39 |
| Clinical Utility Study of EsoGurad on Samples Collected using EsoCheck as a Triage for Endoscopy to Identify Barretts Esophagus | $299,970 | 0 | 16 |
| Analysis andCell sampleCollection- aRetrospective analysis of the clinicalUtility of theEsoCheck device andEsoGuard analysis | $221,226 | 0 | 3 |
| BE2 | $170,917 | 0 | 18 |
| Identifying Individuals at Risk for Barretts Esophagus in a Large Health System Using a Validated Screening Model | $100,000 | 0 | 2 |
| A Multicenter, Single-Arm Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck versus Esophagogastroduodenoscopy for the Diagnosis of Barretts Esophagus in an At-Risk Screening Population | $60,810 | 0 | 18 |
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial | $31,500 | 63 | 63 |
| BE1 | $10,205 | 0 | 2 |
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled | $9,500 | 19 | 19 |
Payments by Medical Specialty
Top Paid Doctors — Page 6
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Philip Tangalos, Do, DO | Student in an Organized Health Care Education/Training Program | Sterling Heights, MI | $480.09 | $0 |
| George Maristela, Md, MD | Family Medicine | Sterling Heights, MI | $480.09 | $0 |
| Dr. Antonio Castellvi, M.d,, M.D, | Family Medicine | Tampa, FL | $471.73 | $0 |
| Steven Schwaitzberg, Md, MD | Surgery | Buffalo, NY | $447.20 | $0 |
| Rachelle Hamblin, Md, MD | Family Medicine | San Antonio, TX | $441.98 | $0 |
| Dr. Michael Ebright, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Stamford, CT | $439.22 | $0 |
| Eric Bour, Md, MD | Surgery | Athens, GA | $420.86 | $0 |
| Ronald Kotfila, Md, MD | Gastroenterology | Flowood, MS | $401.89 | $0 |
| Lauren Havard, M.d, M.D | Family Medicine | Phoenix, AZ | $398.85 | $0 |
| Blair Ball | Family Medicine | El Mirage, AZ | $393.84 | $0 |
| Markeeta Araujo, Aprn, Fnp-C, APRN, FNP-C | Nurse Practitioner | Pahrump, NV | $392.63 | $0 |
| Dr. Adam Smith, D.o, D.O | Specialist | Fort Worth, TX | $391.58 | $0 |
| Dr. Vasilios Gikas, D.o, D.O | Family Medicine | Sterling Heights, MI | $380.06 | $0 |
| Dr. Saied Shemiranei, Md, MD | General Practice | Orlando, FL | $376.44 | $0 |
| Blondena Miley, Fnp, FNP | Family | Lake Havasu City, AZ | $374.76 | $0 |
| Jason Anderson | Family Medicine | Phoenix, AZ | $370.73 | $0 |
| Justin Singh, D.p.m, D.P.M | Foot & Ankle Surgery | Mesa, AZ | $370.73 | $0 |
| Shane Speirs, M.d, M.D | Family Medicine | Avondale, AZ | $370.73 | $0 |
| Cathy Lucas, Cnp, CNP | Family | Ottawa, OH | $370.57 | $0 |
| Joseph Lau, Aprn, APRN | Family | Henderson, NV | $368.78 | $0 |
| Dr. John Erikson Yap, M.d, M.D | Internal Medicine | St George, UT | $366.72 | $0 |
| Mr. Alvin Goldansky, Md, MD | Internal Medicine | Phoenix, AZ | $361.80 | $0 |
| Mr. Carlos Garreton, M.d, M.D | Family Medicine | Phoenix, AZ | $361.80 | $0 |
| Dr. Christopher Canale, Md, MD | Gastroenterology | Bountiful, UT | $358.36 | $0 |
| Dr. Veeral Oza, M.d, M.D | Gastroenterology | Greenville, SC | $355.85 | $0 |
Ad
Top Products
- ESOCHECK CCD CELL COLLECTION DEVICE $91,584
Associated Products (1)
Payment Categories
- Food & Beverage $241,355
- Consulting $462,154
- Travel & Lodging $22,730
- Research $1.3M
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. has made $2.0M in payments to 4,775 healthcare providers, recorded across 8,989 transactions in the CMS Open Payments database. In 2024, the company paid $393,957. The top product by payment volume is ESOCHECK CCD CELL COLLECTION DEVICE ($91,584).
Payments were distributed across 118 medical specialties. The top specialty by payment amount is Gastroenterology ($292,987 to 432 doctors).
Payment categories include: Food & Beverage ($241,355), Consulting ($462,154), Research ($1.3M), Travel & Lodging ($22,730).
Lucid Diagnostics Inc. is associated with 1 products in the CMS Open Payments database.